BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24967406)

  • 1. Serum parathyroid hormone is a new potential risk factor in multiple myeloma.
    Kang MG; Won EJ; Choi HW; Kim HR; Choi HJ; Park HR; Shin JH; Suh SP; Ryang DW; Shin MG
    Biomed Res Int; 2014; 2014():804182. PubMed ID: 24967406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
    García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
    PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Lactate Dehydrogenase Can Be Used as a Factor for Re-Evaluating First-Relapsed Multiple Myeloma.
    Liu Y; Wen L; Chen H; Chen Y; Duan W; Kang Y; Ma L; Huang X; Lu J
    Acta Haematol; 2020; 143(6):559-566. PubMed ID: 32610311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
    Navarro JF; Mora C; Macia M; Garcia J
    Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.
    Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L
    Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia.
    Avram MM; Sreedhara R; Avram DK; Muchnick RA; Fein P
    Am J Kidney Dis; 1996 Dec; 28(6):924-30. PubMed ID: 8957048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
    Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients.
    Jean G; Souberbielle JC; Zaoui E; Lorriaux C; Hurot JM; Mayor B; Deleaval P; Mehdi M; Chazot C
    BMC Nephrol; 2016 Oct; 17(1):153. PubMed ID: 27756251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients.
    Bao L; Wang Y; Lu M; Chu B; Shi L; Gao S; Fang L; Xiang Q
    Cancer Med; 2020 Dec; 9(23):8962-8969. PubMed ID: 33145966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients.
    Suriu C; Akria L; Azoulay D; Shaoul E; Barhoum M; Braester A
    Int J Lab Hematol; 2016 Jun; 38(3):e56-9. PubMed ID: 27018225
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analyses of risk factors for temporarily inhibited parathyroid hormone secretion of postoperative primary hyperparathyroidism].
    Liu X; Zhao T; Wang JC; Shen H; Wang Q; Xin YH; Wei BB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):497-500. PubMed ID: 32842365
    [No Abstract]   [Full Text] [Related]  

  • 12. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
    Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
    Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum lactate dehydrogenase predicts an unfavorable outcome in Chinese elderly patients with multiple myeloma.
    Gu Y; Yuan YH; Xu J; Shi QL; Qu XY; Guo R; Bai H; Xu JD; Li JY; Chen LJ
    Oncotarget; 2017 Jul; 8(29):48350-48361. PubMed ID: 28418851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.
    Yan H; Sharma J; Weber CJ; Guyton RA; Perez S; Thourani VH
    Surgery; 2011 Dec; 150(6):1095-101. PubMed ID: 22136827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.
    van Rhee F; Bolejack V; Hollmig K; Pineda-Roman M; Anaissie E; Epstein J; Shaughnessy JD; Zangari M; Tricot G; Mohiuddin A; Alsayed Y; Woods G; Crowley J; Barlogie B
    Blood; 2007 Aug; 110(3):827-32. PubMed ID: 17416735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens.
    Bai J; Wang J; Yang Y; Zhang W; Wang F; Zhang L; Chen H; Wang X; Feng Y; Shen Y; Huang L; He A
    Hematology; 2019 Dec; 24(1):387-391. PubMed ID: 30890040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Serum Free Light Chain in Multiple Myeloma.
    El Naggar AA; El-Naggar M; Mokhamer el-H; Avad MW
    Egypt J Immunol; 2015; 22(1):69-78. PubMed ID: 26415374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
    Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M
    Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
    Du J; Lu J; Gao W; Liu J; He H; Li L; Li R; Zhou L; Jiang H; Chen W; Fu W; Hou J
    Ann Hematol; 2020 Aug; 99(8):1779-1791. PubMed ID: 32594218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma.
    Larsen JT; Kumar SK; Dispenzieri A; Kyle RA; Katzmann JA; Rajkumar SV
    Leukemia; 2013 Apr; 27(4):941-6. PubMed ID: 23183428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.